Form Filed By RAAB MICHAEL
Fri, Mar 7, 2025
Go to original document
ARDELYX, INC. (ARDX)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2025-03-07
Common Stock
Derivative conversion
M
Type
Acquired 20,834 shares @ $0.99 per share
1,676,806 shares
Direct
2025-03-07
Common Stock
Sale
S
Type
Disposed 41,668 shares @ $5.36 per share
1,635,138 shares
Direct
Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
24,364 shares
Family Trust
Indirect
Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
1,000 shares
Family Trust
Indirect
Footnotes
1. Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024.
2. Transaction was executed in multiple trades in prices ranging from $5.28 to $5.47, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3. The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
4. The shares are owned directly by trusts for the benefit of the Reporting Person's children.
5. The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.